Relationship between Pharmacokinetic/Pharmacodynamic Target Attainment and Microbiological Outcome in Critically Ill COVID-19 Patients with Documented Gram-Negative Superinfections Treated with TDM-Guided Continuous-Infusion Meropenem.

Sanz Codina M, Gatti M, Troisi C, Fornaro G, Pasquini Z, Trapani F, Zanoni A, Caramelli F, Viale P, Pea F

Open source

DOI
10.3390/pharmaceutics14081585
Published
2022 Jul 29
Container
Pharmaceutics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics14081585,
  title = {Relationship between Pharmacokinetic/Pharmacodynamic Target Attainment and Microbiological Outcome in Critically Ill COVID-19 Patients with Documented Gram-Negative Superinfections Treated with TDM-Guided Continuous-Infusion Meropenem.},
  author = {Sanz Codina M and Gatti M and Troisi C and Fornaro G and Pasquini Z and Trapani F and Zanoni A and Caramelli F and Viale P and Pea F},
  year = {2022},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics14081585},
  url = {https://doi.org/10.3390/pharmaceutics14081585}
}

RIS

TY  - JOUR
TI  - Relationship between Pharmacokinetic/Pharmacodynamic Target Attainment and Microbiological Outcome in Critically Ill COVID-19 Patients with Documented Gram-Negative Superinfections Treated with TDM-Guided Continuous-Infusion Meropenem.
AU  - Sanz Codina M
AU  - Gatti M
AU  - Troisi C
AU  - Fornaro G
AU  - Pasquini Z
AU  - Trapani F
AU  - Zanoni A
AU  - Caramelli F
AU  - Viale P
AU  - Pea F
PY  - 2022
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics14081585
UR  - https://doi.org/10.3390/pharmaceutics14081585
ER  - 

APA

M, S. C., M, G., C, T., G, F., Z, P., F, T., A, Z., F, C., P, V., & F, P. (2022). Relationship between Pharmacokinetic/Pharmacodynamic Target Attainment and Microbiological Outcome in Critically Ill COVID-19 Patients with Documented Gram-Negative Superinfections Treated with TDM-Guided Continuous-Infusion Meropenem.. Pharmaceutics. https://doi.org/10.3390/pharmaceutics14081585

Source records